Barely Significant
← all excerpts

Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology.

Neurol Ther · 2019 · PMC6908530 · PMID 31833027

Europe PMCDOI
2
hedged sentences
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
In this study, the increase in Aβ42 levels in plasma samples from subjects with AD was highly significant ( P < 0.001), consistent with other IMR findings.

also in 132,142 other papers

almost significantno p-value reported
Plasma AD Marker Levels by Clinical Diagnosis Groups IMR assays have detected significant or almost significant increases in plasma Aβ42 in clinically diagnosed AD cases.

also in 1,858 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.